Jay Flatley

Type: Person
Name: Jay Flatley
First reported Jul 21 2014 - Updated Jul 21 2014 - 1 reports

San Diego City Council To Consider $1.5M Tax Rebate For Illumina

The San Diego City Council will vote Monday on whether to approve a deal with the medical device company Illumina that will keep its manufacturing facilities in the city for 10 years in exchange for a $1.5 million tax rebate.Mayor Kevin Faulconer announced ... [Published KPBS - Jul 21 2014]
First reported Jul 17 2014 - Updated Jul 17 2014 - 1 reports

Leadership Appointments, Earnings Conference Calls, Milestone Payments, and Technical Updates - Analyst Notes on Illumina, Alexion, Incyte, Clovis and Keryx

/PRNewswire/ --Today, Analysts Review released its analysts' notes regarding Illumina Inc. ( NASDAQ: ILMN ), Alexion Pharmaceuticals, Inc. ( NASDAQ: ALXN ), Incyte Corporation ( NASDAQ: INCY ), Clovis Oncology, Inc. ( NASDAQ: CLVS ) and Keryx Biopharmaceuticals ... [Published SearchBug - Jul 17 2014]
First reported Jul 15 2014 - Updated Jul 16 2014 - 1 reports

Ilumina, City Reach Proposed Deal

Under the 10-year agreement, Ilumina will keep 300 middle-class manufacturing jobs in San Diego and receive a tax break up to $1.5 millionNBC 7Mayor Kevin Faulconer (L) shakes hands with Ilumina CEO Jay Flatley on Tuesday, July 15, 2014.One of the nation's ... [Published NBC San Diego - Jul 15 2014]
First reported Jul 14 2014 - Updated Jul 15 2014 - 1 reports

Illumina Names Tina S. Nova as Senior Vice President and General Manager of Oncology

SAN DIEGO--(BUSINESS WIRE)--Jul. 14, 2014-- Illumina Inc"Tina has worked at the forefront of personalized cancer diagnostics and is an excellent addition to Illumina's leadership team given our commitment to working with the oncology community to transform ... [Published BusinessWeek - Jul 14 2014]
First reported Jul 09 2014 - Updated Jul 09 2014 - 3 reports

Illumina to Announce Second Quarter 2014 Financial Results on Wednesday, July 23, 2014

SAN DIEGO--(EON: Enhanced Online News)--Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for second quarter 2014 following the close of market on Wednesday, July 23, 2014. On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern ... [Published EON Science - Jul 09 2014]
First reported Jun 26 2014 - Updated Jun 26 2014 - 1 reports

Personalized Medicine World Conference Honors Teva's Dr. Michael Hayden with 2014 Luminary Award

The Personalized Medicine World Conference (PMWC) reported that Dr. Michael Hayden, President of Global R&D and Chief Scientific Officer of Teva Pharmaceuticals, is the recipient of the 2014 PMWC Luminary Award, for his contribution to the advancement ... [Published Individual.com - Jun 26 2014]
First reported Jun 24 2014 - Updated Jun 24 2014 - 1 reports

Reaction to the $1,000 Genome

System promises to sequence tens of thousands of human whole genomes a year in a single laboratory. What do the first customers think? Life science technology company Illumina recently launched a sequencing platform that it claims will enable the $1,000 ... [Published I Am Biotech - Jun 24 2014]
First reported Jun 23 2014 - Updated Jun 23 2014 - 1 reports

Personalized Medicine World Conference Luminary Award Granted to Dr. Michael Hayden

SAN JOSE, Calif. & HERTZELIA, Israel--(BUSINESS WIRE)-- The Personalized Medicine World Conference (PMWC) announced that Dr. Michael Hayden, President of Global R&D and Chief Scientific Officer of Teva Pharmaceuticals, is the recipient of the 2014 PMWC ... [Published CNBC - Jun 23 2014]
First reported Jun 21 2014 - Updated Jun 21 2014 - 1 reports

Glossary of terms

Fiscal year (FY): The FY of some firms ends in December while others may end in March, June or September.Total shareholder return: A measurement of stock price gains or declines, plus dividends paid, over time. The results are annualized. That means they’re ... [Published U-T San Diego - Jun 21 2014]
First reported May 05 2014 - Updated May 05 2014 - 3 reports

Illumina to Webcast Live Presentation at Upcoming Investment Conferences in May and June

SAN DIEGO--(EON: Enhanced Online News)--Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the Company’s presentation at three upcoming investment conferences. Illumina will webcast its presentation at the Bank of America Merrill Lynch ... [Published EON Science - May 05 2014]
First reported Apr 07 2014 - Updated Apr 08 2014 - 3 reports

Illumina to Announce First Quarter 2014 Financial Results on Tuesday, April 22, 2014

SAN DIEGO--(EON: Enhanced Online News)--Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for first quarter 2014 following the close of market on Tuesday, April 22, 2014. On the same day, at 2:30 p.m. Pacific Time (5:30 p.m. Eastern ... [Published EON Science - Apr 07 2014]
First reported Feb 21 2014 - Updated Feb 21 2014 - 1 reports

Mapping the human genome

Illumina CEO Jay Flatley on reducing the cost of mapping the human genome. ... [Published FOX Business - Video - Feb 21 2014]

Quotes

...Jay Flatley , CEO of Illumina commented, "tina has worked at the forefront of personalized cancer diagnostics and is an excellent addition to illumina's leadership team given our commitment to working with the oncology community to transform the field." Ms. Nova previously served as the COO of Selective Genetics, a biotechnology company, and also held research and management positions with Ligand Ph...

More Content

All (23) | News (11) | Reports (0) | Blogs (12) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
San Diego City Council To Consider $1.5M Tax Re... [Published KPBS - Jul 21 2014]
Leadership Appointments, Earnings Conference Ca... [Published SearchBug - Jul 17 2014]
Ilumina, City Reach Proposed Deal [Published NBC San Diego - Jul 15 2014]
Illumina expanding, with San Diego's help [Published U-T San Diego - Jul 15 2014]
Illumina Names Tina S. Nova As Senior Vice Pres... [Published Benzinga.com - Jul 14 2014]
Illumina Names Tina S. Nova as Senior Vice Pres... [Published BusinessWeek - Jul 14 2014]
Illumina to Announce Second Quarter 2014 Financ... [Published EON Science - Jul 09 2014]
Illumina to Announce Second Quarter 2014 Financ... [Published Business Wire Science: Science News - Jul 09 2014]
Illumina to Announce Second Quarter 2014 Financ... [Published Business Wire Health News - Jul 09 2014]
Personalized Medicine World Conference Honors T... [Published Individual.com - Jun 26 2014]
Reaction to the $1,000 Genome [Published I Am Biotech - Jun 24 2014]
Personalized Medicine World Conference Luminary... [Published CNBC - Jun 23 2014]
Glossary of terms [Published U-T San Diego - Jun 21 2014]
Illumina to Webcast Live Presentation at Upcomi... [Published EON Science - May 05 2014]
Illumina to Webcast Live Presentation at Upcomi... [Published Business Wire Science: Science News - May 05 2014]
Illumina to Webcast Live Presentation at Upcomi... [Published Business Wire Health News - May 05 2014]
Illumina to Announce First Quarter 2014 Financi... [Published EON Science - Apr 07 2014]
Illumina to Announce First Quarter 2014 Financi... [Published Business Wire Science: Science News - Apr 07 2014]
Illumina to Announce First Quarter 2014 Financi... [Published Business Wire Health News - Apr 07 2014]
WuXi purchases Illumina HiSeq X Ten sequencing ... [Published PharmaBiz - Mar 11 2014]
Mapping the human genome [Published FOX Business - Video - Feb 21 2014]
Genome Management, Genome Factories and Other A... [Published mendelspod.com - Feb 11 2014]
J.P. Morgan: Pharma’s Agenda for 2014 [Published Pharmaceutical Executive - Jan 20 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Illumina to Announce Second Quarter 2014 Financ... [Published EON Science - Jul 09 2014]
SAN DIEGO--(EON: Enhanced Online News)--Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for second quarter 2014 following the close of market on Wednesday, July 23, 2014. On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern ...
Illumina to Announce Second Quarter 2014 Financ... [Published Business Wire Science: Science News - Jul 09 2014]
SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for second quarter 2014 following the close of market on Wednesday, July 23, 2014. On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Jay ...
Illumina to Announce Second Quarter 2014 Financ... [Published Business Wire Health News - Jul 09 2014]
SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for second quarter 2014 following the close of market on Wednesday, July 23, 2014. On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Jay ...
Reaction to the $1,000 Genome [Published I Am Biotech - Jun 24 2014]
System promises to sequence tens of thousands of human whole genomes a year in a single laboratory. What do the first customers think? Life science technology company Illumina recently launched a sequencing platform that it claims will enable the $1,000 ...
Illumina to Webcast Live Presentation at Upcomi... [Published EON Science - May 05 2014]
SAN DIEGO--(EON: Enhanced Online News)--Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the Company’s presentation at three upcoming investment conferences. Illumina will webcast its presentation at the Bank of America Merrill Lynch ...
1 2 3
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.